Summary
Axon Enterprise, Inc. reported strong revenue growth for the second quarter of 2025, with net sales increasing by 32.8% year-over-year to $668.5 million. This growth was driven by robust performance in both the Connected Devices segment (up 28.6%) and the Software and Services segment (up 38.8%). Despite the top-line growth, the company reported a net loss from operations of $1.0 million for the quarter, a decrease from an income of $33.8 million in the prior year, primarily due to a significant increase in operating expenses, particularly in selling, general, and administrative costs driven by higher stock-based compensation and increased headcount. Financially, Axon bolstered its liquidity position significantly, with cash and cash equivalents increasing by $160.7 million to $615.5 million, and total available-for-sale investments growing by $1.1 billion to $1.5 billion, largely following the issuance of $1.75 billion in Senior Notes in March 2025. The company also experienced a substantial increase in financing cash flows due to these note issuances and ATM equity offerings. While revenue growth is positive, investors should monitor the increasing operating expenses and the impact of stock-based compensation, alongside the company's substantial debt load.
Financial Highlights
53 data points| Revenue | $668.54M |
| Cost of Revenue | $264.80M |
| Gross Profit | $403.74M |
| R&D Expenses | $162.57M |
| SG&A Expenses | $242.21M |
| Operating Expenses | $404.78M |
| Operating Income | -$1.04M |
| Net Income | $36.12M |
| EPS (Basic) | $0.46 |
| EPS (Diluted) | $0.44 |
| Shares Outstanding (Basic) | 78.00M |
| Shares Outstanding (Diluted) | 82.06M |
Key Highlights
- 1Net sales increased by 32.8% to $668.5 million for Q2 2025 compared to Q2 2024.
- 2Connected Devices segment revenue grew by 28.6%, driven by TASER and Platform Solutions, while Software and Services revenue increased by 38.8% due to user growth and premium feature adoption.
- 3Operating expenses rose significantly, leading to a loss from operations of $1.0 million in Q2 2025, compared to income from operations of $33.8 million in Q2 2024.
- 4Stock-based compensation expense saw a substantial increase, impacting gross margin and operating expenses.
- 5Cash and cash equivalents increased by $160.7 million to $615.5 million, and short-term investments grew by $1.1 billion to $1.5 billion.
- 6The company issued $1.75 billion in Senior Notes (2030 and 2033), significantly boosting financing activities and liquidity.
- 7There was a reported material weakness in internal control over financial reporting related to revenue recognition, though efforts to remediate are underway.